Cargando…
Candidates for Repurposing as Anti-Virulence Agents Based on the Structural Profile Analysis of Microbial Collagenase Inhibitors
The pharmacological inhibition of the bacterial collagenases (BC) enzymes is considered a promising strategy to block the virulence of the bacteria without targeting the selection mechanism leading to drug resistance. The chemical structures of the Clostridium perfringens collagenase A (ColA) inhibi...
Autores principales: | Nitulescu, Georgiana, Nitulescu, George Mihai, Zanfirescu, Anca, Mihai, Dragos Paul, Gradinaru, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780423/ https://www.ncbi.nlm.nih.gov/pubmed/35056958 http://dx.doi.org/10.3390/pharmaceutics14010062 |
Ejemplares similares
-
Discovery of New Microbial Collagenase Inhibitors
por: Nitulescu, Georgiana, et al.
Publicado: (2022) -
Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing
por: Zanfirescu, Anca, et al.
Publicado: (2021) -
Cetirizine and Levetiracetam as Inhibitors of Monoacylglycerol Lipase: Investigating Their Repurposing Potential as Novel Osteoarthritic Pain Therapies
por: Andrei, Corina, et al.
Publicado: (2023) -
Targeting Bacterial Sortases in Search of Anti-virulence Therapies with Low Risk of Resistance Development
por: Nitulescu, Georgiana, et al.
Publicado: (2021) -
In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity
por: Andrei, Corina, et al.
Publicado: (2022)